Status:
COMPLETED
Uses of Immunosuppression Therapy in Patients With Liver Transplantation
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Evidence of Liver Transplantation
Eligibility:
All Genders
20+ years
Brief Summary
Conventionally, the outcome of liver transplantation is usually reported in terms of graft and patient survival, medical and surgical complications, but lack of health-related quality of life (HRQOL) ...
Detailed Description
Specific aims are proposed to achieve in this study: 1. To compare graft and patient survival rate, incidence of treatment-related adverse effects between different patterns of immunosuppression comb...
Eligibility Criteria
Inclusion
- Aim 1:
- age at liver transplantation is at least 20 years
- Aim 2:
- age at liver transplantation is at least 20 years
Exclusion
- deceased patient
- cannot obtain inform consent
- age \<20 years
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT01834690
Start Date
April 1 2013
End Date
December 1 2014
Last Update
February 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 833